Irbesartan
Home / API - Commercial / Irbesartan
CAS No.
138402-11-6
Therapeutic Category
- Anti-hypertensive
Innovator Brand
KARVEA , APROVEL , AVALIVE , AVAPRO
GMP
Available
DMF
Not Available
Filed
Under Filing
-
Sample
Available
Indication
Avapro is an angiotensin ii receptor blocker (arb) indicated for:
Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.